Investment News

Guinness Ventures announces investment in Evaro

Evaro is reshaping how people access healthcare. By enabling trusted consumer brands such as Clue and Lovehoney Group to offer prescription services directly to their users, the company has built the infrastructure required to make healthcare as accessible as online banking. 

With over 2 million patients already served, founders Thuria Wenbar, Oskar Wenbar, and the wider team are building a platform that helps relieve pressure on the NHS while enabling safe and compliant entry into healthcare for consumer brands. 

We were delighted to support Evaro last year, alongside AlbionVC, Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC and BBI as the business continues to scale.

 

Resources

View more

18 December 2025
News

Guinness Ventures announces investment in GlycanAge

Guinness Ventures announces investment in GlycanAge

We are delighted to have participated in GlycanAge’s $8.7m (€7.4m) investment targeted funding round. GlycanAge is a biotechnology company transforming how individuals and healthcare providers understand healthy ageing through advanced glycan analysis.

Read more
21 September 2025
News

Guinness Ventures announces investment in YASO

Guinness Ventures announces investment in YASO

We are delighted to announce our investment in YASO, the operating system for global brands in China, following the close of its £8.26 million Series A funding round.

Read more
10 July 2025
News

Guinness Ventures announces investment in Goodrays

Guinness Ventures announces investment in Goodrays

We are pleased to announce our investment in Goodrays.

Founded by Eoin Keenan in 2020, Goodrays is redefining the functional drinks market with a mission to bring mental well-being to the forefront of the food and drinks industry.

Read more